|
|
||||||||
We have studied the effects of vasopressin and tetradecanoyl phorbol acetate (TPA) on cytosolic free Ca2+ ([Ca2+]i) and insulin release in HIT-T15 β-cells. Saturable binding of [3H] [Arg8]-vasopressin to HIT cell microsomes indicated a single class of receptors with a dissociation constant (Kd) of 2.5 nM and a total number of binding sites (Bmax) equal to 120 fmol/mg protein. [Arg8]-vasopressin (0.1–100 nM) elicited dose-dependent insulin release from HIT cells by up to 25-fold. This increase was dependent on the presence of extracellular glucose and was blocked by omission of extracellular Ca2+ or addition of verapamil. The stimulation was biphasic; a rapid but short-lived large increase in release was followed by a smaller sustained rise. Vasopressin also evoked a marked, concentration-dependent increase in [Ca2+]i which was also biphasic; an initial spike was followed by a sustained elevation. This increase also required glucose and was blocked by the absence of extracellular Ca2+ or the addition of verapamil. Pretreatment of the cells with TPA overnight to deplete protein kinase C activity did not affect the [Ca2+]i or insulin responses to vasopressin. However, short-term exposure to TPA markedly reduced glucose-induced steady-state [Ca2+]i, despite potentiating glucose-stimulated insulin release sevenfold, and blocked the [Ca2+]i increase induced by vasopressin. These inhibitory effects of TPA were absent in protein kinase C-depleted cells and were prevented by staurosporine. TPA had no significant effect on vasopressin-induced insulin release. Vasopressin did not modify the activity of ATP-sensitive K+ channels. These data indicate that vasopressin-induced insulin release is associated with a large increase in [Ca2+]i via increased Ca2+ entry and that this signal is markedly reduced by protein kinase C activation. Thus, protein kinase C does not have a direct role in vasopressin-induced insulin release. Simultaneous addition of vasopressin and TPA promotes insulin release, possibly through increased sensitivity of the secretory system to Ca2+ on activation of protein kinase C by TPA.
This article has been cited by other articles:
![]() |
M. J. Holness, N. D. Smith, G. K. Greenwood, and M. C. Sugden Acute {omega}-3 Fatty Acid Enrichment Selectively Reverses High-Saturated Fat Feeding-Induced Insulin Hypersecretion But Does Not Improve Peripheral Insulin Resistance Diabetes, February 1, 2004; 53(90001): S166 - 171. [Abstract] [Full Text] |
||||
![]() |
M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden Diabetogenic Impact of Long-Chain {omega}-3 Fatty Acids on Pancreatic {beta}-Cell Function and the Regulation of Endogenous Glucose Production Endocrinology, September 1, 2003; 144(9): 3958 - 3968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sugden, G. K. Greenwood, N. D. Smith, and M. J. Holness Peroxisome Proliferator-Activated Receptor-{alpha} Activation during Pregnancy Attenuates Glucose-Stimulated Insulin Hypersecretion in Vivo by Increasing Insulin Sensitivity, without Impairing Pregnancy-Induced Increases in {beta}-Cell Glucose Sensing and Responsiveness Endocrinology, January 1, 2003; 144(1): 146 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schofl, J. Borger, T. Mader, M. Waring, A. von zur Muhlen, and G. Brabant Tolbutamide and diazoxide modulate phospholipase C-linked Ca2+ signaling and insulin secretion in beta -cells Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E639 - E647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |